In the Neuroscience News study, the focus is on a recently published research review by researchers from University College London (UCL) regarding drugs known as GLP-1 receptor agonists that are already prescribed for treating diabetes and obesity but may influence the symptoms associated with binge eating as well
With new approvals for cardiovascular risk reduction and OSA, GLP1s are reshaping treatment paradigms across comorbid conditions and gaining traction with a broader set of providers
This really suggests to me that affordability is a big concern in our healthcare system at multiple levels, Sinaiko said
Underlying Conditions : Persistent fatigue may also be due to coexisting conditions unrelated to semaglutide, such as anemia, thyroid dysfunction, vitamin B12 deficiency, or vitamin D deficiency
Monthly virtual doctor visits
For Type 1 diabetes and insulin users, prioritize accuracy, alert reliability, and ecosystem integration